Amy Lin
Impact in
- Dermatology top 0.5%
- Skin Protection and Aging
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Virology 2
- Co-authors
- Howard P. BadenDouglas E. BrashJeffrey A. RudolphGreg J. McKennaAlan J. HalperinTony Wyss‐CorayEliezer MasliahCaroline B. Ho
- Journals
- Human Gene Therapy (3 papers)Proceedings of the National Academy of Sciences (3 papers)Cancer Research (3 papers)Journal of Pharmaceutical Sciences (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Amy Lin
46 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Dermatology 571
- Neurology 383
- Oncology 1.1k
- Molecular Biology 2.7k
- Biological Psychiatry 97
Countries citing papers authored by Amy Lin
This map shows the geographic impact of Amy Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Lin more than expected).
Fields of papers citing papers by Amy Lin
This network shows the impact of papers produced by Amy Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Lin. The network helps show where Amy Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2019 | 5 | |
| 4 | 2016 | 3 | |
| 5 | 2014 | 16 | |
| 6 | 2013 | 5 | |
| 7 | 2010 | 462 | |
| 8 | 2009 | 462 | |
| 9 | 2009 | 51 | |
| 10 | 2009 | 7 | |
| 11 | 2009 | 13 | |
| 12 | 2009 | 41 | |
| 13 | Quarfloxin (CX-3543) disrupts the Nucleolin/ rDNA quadruplex complexes, inhibits the elongation by RNA Polymerase I and exhibits potent antitumor activity in models of cancer | 2008 | 6 |
| 14 | 2007 | 64 | |
| 15 | 2007 | 119 | |
| 16 | 2006 | 287 | |
| 17 | 2005 | 90 | |
| 18 | 2002 | 20 | |
| 19 | 1998 | 110 | |
| 20 | 1997 | 23 |
About Amy Lin
Amy Lin is a scholar working on Business and International Management, Virology, Molecular Biology, Oncology and Pharmacology, having authored 46 papers that have together received 4.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), RNA Interference and Gene Delivery (6 papers), Genetic Neurodegenerative Diseases (5 papers), DNA Repair Mechanisms (4 papers), Mitochondrial Function and Pathology (4 papers), CRISPR and Genetic Engineering (4 papers), CAR-T cell therapy research (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Dermatology (571 citations), Neurology (383 citations), Oncology (1.1k citations), Molecular Biology (2.7k citations) and Biological Psychiatry (97 citations). Amy Lin has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Howard P. Baden, Douglas E. Brash, Jeffrey A. Rudolph, Greg J. McKenna, Alan J. Halperin, Tony Wyss‐Coray, Eliezer Masliah, Caroline B. Ho, Kenna Anderes and Chris Proffitt. Their work appears in journals such as Human Gene Therapy, Proceedings of the National Academy of Sciences, Cancer Research, Journal of Pharmaceutical Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.